{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:29:56Z","timestamp":1794839396254,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative pain control in cardiac surgery is often managed with opioid medications. Insufficient analgesia can result in complications including splinting, pneumonia, and delay of appropriate rehabilitation. Given the risks and adverse effects of opioids including sedation, respiratory depression, delirium, and decreased gastrointestinal motility, hyperalgesia and potential for addiction, strategies for opioid reduction are likely to improve outcomes, therefore multimodal opioid sparing pain regimens are preferred. Recently, there is increased evidence that low dose Ketamine, an N-methyl-D-Aspartate (NMDA) receptor antagonist, is safe and effective for analgesia in postoperative patients and may be appropriate to this setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single center, retrospective, observational, cohort study over a one year period involving postoperative adult cardiac surgery comparing those who received a single dose of postoperative ketamine, 0.3\u00a0mg\/kg over 30\u00a0min, with those who did not receive any ketamine. Other analgesic protocols were similar between groups and did not include additional ketamine. A total of 120 patient charts were reviewed, of which 96 met inclusion criteria, 32 in the ketamine group and 64 in the standard care group. Charts were reviewed for opioid and other pain medication requirements during the postoperative period and on discharge, and for secondary outcomes: hospital length of stay, ICU length of stay, in-hospital and 30-day mortality, 30-day readmission, and rates of delirium, emergence reactions, and need for escalated respiratory support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The group who received postoperative ketamine required 28.8 morphine milligram equivalents (MME) less postoperative opioid (90.1\u00a0mg vs 118.9\u00a0mg,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.167), and was prescribed an average of 15.8 MME less on discharge (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Intraoperatively, both groups received 1000\u00a0mg acetaminophen, 2\u00a0mg intravenous morphine and 100 mcg fentanyl, 26 MME, by protocol. No ketamine was administered intraoperatively or preoperatively. The groups differed in respect to operation type and controlling for this parameter failed to achieve significance in needs during admission (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.215), but remained significant on discharge (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). The non-ketamine group received more ketorolac (15.5 vs 10.1,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.06). The ketamine group required less acetaminophen but more gabapentin. There was no difference in hospital or ICU length of stay. There was no delirium or mortality in either group. Respiratory depression occurred in 15 patients who all subsequently received ketamine. No patient developed respiratory depression after ketamine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ketamine may be a reasonable choice for postoperative cardiac surgery analgesia and may reduce the need for opioids on discharge, and possibly during admission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-025-03405-x","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:11:35Z","timestamp":1743739895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ketamine as part of multi-modal analgesia may reduce opioid requirements following cardiac surgery: a retrospective observational cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"James","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Khilkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Elkomos-Botros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"3405_CR1","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/JPR.S144066","volume":"10","author":"TJ Gan","year":"2017","unstructured":"Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287\u201398. https:\/\/doi.org\/10.2147\/JPR.S144066.","journal-title":"J Pain Res"},{"issue":"3","key":"3405_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0033-1351138","volume":"26","author":"V Garimella","year":"2013","unstructured":"Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191\u20136. https:\/\/doi.org\/10.1055\/s-0033-1351138.","journal-title":"Clin Colon Rectal Surg"},{"issue":"2","key":"3405_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"M Lee","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145\u201361.","journal-title":"Pain Physician"},{"issue":"8","key":"3405_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","volume":"154","author":"DT Engelman","year":"2019","unstructured":"Engelman DT, Ben Ali W, Williams JB, et al. Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations. JAMA Surg. 2019;154(8):755\u201366. https:\/\/doi.org\/10.1001\/jamasurg.2019.1153.","journal-title":"JAMA Surg"},{"key":"3405_CR5","doi-asserted-by":"publisher","first-page":"749837","DOI":"10.1155\/2015\/749837","volume":"2015","author":"BM Radvansky","year":"2015","unstructured":"Radvansky BM, Shah K, Parikh A, Sifonios AN, Le V, Eloy JD. Role of ketamine in acute postoperative pain management: a narrative review. Biomed Res Int. 2015;2015:749837. https:\/\/doi.org\/10.1155\/2015\/749837.","journal-title":"Biomed Res Int"},{"issue":"16","key":"3405_CR6","doi-asserted-by":"publisher","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","volume":"95","author":"A Alkhachroum","year":"2020","unstructured":"Alkhachroum A, Der-Nigoghossian CA, Mathews E, Massad N, Letchinger R, Doyle K, Chiu WT, Kromm J, Rubinos C, Velazquez A, Roh D, Agarwal S, Park S, Connolly ES, Claassen J. Ketamine to treat super-refractory status epilepticus. Neurology. 2020;95(16):e2286\u201394. https:\/\/doi.org\/10.1212\/WNL.0000000000010611.","journal-title":"Neurology"},{"issue":"4","key":"3405_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0149-7634(01)00018-5","volume":"25","author":"AY Bespalov","year":"2001","unstructured":"Bespalov AY, Zvartau EE, Beardsley PM. Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. Neurosci Biobehav Rev. 2001;25(4):343\u201353. https:\/\/doi.org\/10.1016\/s0149-7634(01)00018-5.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"3405_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/bja\/aeq341","volume":"106","author":"ID Welters","year":"2011","unstructured":"Welters ID, Feurer MK, Preiss V, M\u00fcller M, Scholz S, Kwapisz M, Mogk M, Neuh\u00e4user C. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth. 2011;106(2):172\u20139. https:\/\/doi.org\/10.1093\/bja\/aeq341.","journal-title":"Br J Anaesth"},{"issue":"4","key":"3405_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/med4.45","volume":"1","author":"P OlujimiOdutola","year":"2023","unstructured":"OlujimiOdutola P, Gupta R. IV ketamine infusion therapy for chronic pain: a systematic review and meta-analysis. Med Adv. 2023;1(4):394\u2013407. https:\/\/doi.org\/10.1002\/med4.45.","journal-title":"Med Adv"},{"issue":"5","key":"3405_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4103\/psychiatry.IndianJPsychiatry_484_18","volume":"61","author":"S Mandal","year":"2019","unstructured":"Mandal S, Sinha VK, Goyal N. Efficacy of ketamine therapy in the treatment of depression. Indian J Psychiatry. 2019;61(5):480\u20135. https:\/\/doi.org\/10.4103\/psychiatry.IndianJPsychiatry_484_18.","journal-title":"Indian J Psychiatry"},{"key":"3405_CR11","unstructured":"FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor\u2019s office or clinic. Website: Food and Drug Administration. 5 Mar 2019, accessed 6 Jun 2024. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified"},{"issue":"3","key":"3405_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bja.2019.05.043","volume":"123","author":"JM Riddell","year":"2019","unstructured":"Riddell JM, Trummel JM, Onakpoya IJ. Low-dose ketamine in painful orthopaedic surgery: a systematic review and meta-analysis. Br J Anaesth. 2019;123(3):325\u201334. https:\/\/doi.org\/10.1016\/j.bja.2019.05.043.","journal-title":"Br J Anaesth"},{"key":"3405_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/ALN.0b013e3181e90914","volume":"113","author":"RW Loftus","year":"2010","unstructured":"Loftus RW, Yeager MP, Clark JA, Brown JR, Abdu WA, Sengupta DK, Beach ML. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010;113:639\u201346. https:\/\/doi.org\/10.1097\/ALN.0b013e3181e90914.","journal-title":"Anesthesiology"},{"issue":"4","key":"3405_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4103\/aca.ACA_54_17","volume":"20","author":"J Cogan","year":"2017","unstructured":"Cogan J, Lalumi\u00e8re G, Vargas-Schaffer G, Deschamps A, Yegin Z. Low-dose intravenous ketamine for postcardiac surgery pain: effect on opioid consumption and the incidence of chronic pain. Ann Card Anaesth. 2017;20(4):395\u20138. https:\/\/doi.org\/10.4103\/aca.ACA_54_17.","journal-title":"Ann Card Anaesth"},{"issue":"10","key":"3405_CR15","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1053\/j.jvca.2024.04.039","volume":"38","author":"M Abdelfattah","year":"2024","unstructured":"Abdelfattah M, Abdelbaser I, AliAwad K, Atallah AM, Sanad M, Sayedalahl M. Effect of low-dose ketamine infusion on opioid consumption in children undergoing open cardiac surgery: a randomized controlled double-blind study. J Cardiothoracic and Vas Anes. 2024;38(10):2349\u201355. https:\/\/doi.org\/10.1053\/j.jvca.2024.04.039.","journal-title":"J Cardiothoracic and Vas Anes"},{"issue":"7","key":"3405_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1399-6576.2009.01978.x","volume":"53","author":"JA Hudetz","year":"2009","unstructured":"Hudetz JA, Iqbal Z, Gandhi SD, Patterson KM, Byrne AJ, Hudetz AG, Pagel PS, Warltier DC. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand. 2009;53(7):864\u201372. https:\/\/doi.org\/10.1111\/j.1399-6576.2009.01978.x.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"3405_CR17","doi-asserted-by":"publisher","first-page":"CD012033","DOI":"10.1002\/14651858.CD012033.pub4","volume":"12","author":"EC Brinck","year":"2018","unstructured":"Brinck EC, Tiippana E, Heesen M, Bell RF, Straube S, Moore RA, Kontinen V. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018;12(12):CD012033. https:\/\/doi.org\/10.1002\/14651858.CD012033.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"3405_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12871-021-01362-1","volume":"21","author":"C Aguerreche","year":"2021","unstructured":"Aguerreche C, Cadier G, Beurton A, et al. Feasibility and postoperative opioid sparing effect of an opioid-free anaesthesia in adult cardiac surgery: a retrospective study. BMC Anesthesiol. 2021;21:166. https:\/\/doi.org\/10.1186\/s12871-021-01362-1.","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"3405_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1213\/01.ANE.0000133913.07342.B9","volume":"99","author":"P Lahtinen","year":"2004","unstructured":"Lahtinen P, Kokki H, Hakala T, Hynynen M. S(+)-ketamine as an analgesic adjunct reduces opioid consumption after cardiac surgery. Anesth Analg. 2004;99(5):1295\u2013301. https:\/\/doi.org\/10.1213\/01.ANE.0000133913.07342.B9.","journal-title":"Anesth Analg"},{"key":"3405_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/ALN.0000000000002751","volume":"131","author":"S Anwar","year":"2019","unstructured":"Anwar S, Cooper J, Rahman J, Sharma C, Langford R. Prolonged perioperative use of pregabalin and ketamine to prevent persistent pain after cardiac surgery. Anesthesiology. 2019;131:119\u201331. https:\/\/doi.org\/10.1097\/ALN.0000000000002751.","journal-title":"Anesthesiology"},{"issue":"3","key":"3405_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.jvca.2019.10.010","volume":"34","author":"M Cameron","year":"2020","unstructured":"Cameron M, Tam K, Al Wahaibi K, Charghi R, B\u00e9\u00efque F. Intraoperative ketamine for analgesia post-coronary artery bypass surgery: a randomized, controlled, double-blind clinical trial. J Cardiothorac Vasc Anesth. 2020;34(3):586\u201391. https:\/\/doi.org\/10.1053\/j.jvca.2019.10.010.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3405_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/JPR.S389564","volume":"16","author":"LV Doan","year":"2023","unstructured":"Doan LV, Li A, Brake L, Ok D, Jee HJ, Park H, Cuevas R, Calvino S, Guth A, Schnabel F, Hiotis K, Axelrod D, Wang J. Single-dose of postoperative ketamine for postoperative pain after mastectomy: a pilot randomized controlled trial. J Pain Res. 2023;16:881\u201392.","journal-title":"J Pain Res"},{"key":"3405_CR23","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.2147\/JPR.S276710","volume":"13","author":"V Varas","year":"2020","unstructured":"Varas V, Bertinelli P, Carrasco P, Souper N, \u00c1lvarez P, Danilla S, Ega\u00f1a JI, Penna A, Sep\u00falveda S, Arancibia V, \u00c1lvarez MG, Vergara R. Intraoperative ketamine and magnesium therapy to control postoperative pain after abdominoplasty and\/or liposuction: a clinical randomized trial. J Pain Res. 2020;13:2937\u201346.","journal-title":"J Pain Res"},{"key":"3405_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2021\/5520517","volume":"5520517","author":"MT Seman","year":"2021","unstructured":"Seman MT, Malan SH, Buras MR, Butterfield RJ, Harold KL, Madura JA, Rosenfeld DM, Gorlin AW. Low-dose ketamine infusion for perioperative pain management in patients undergoing laparoscopic gastric bypass: a prospective randomized controlled trial. Anesthesiol Res Pract. 2021;5520517:11. https:\/\/doi.org\/10.1155\/2021\/5520517.","journal-title":"Anesthesiol Res Pract"},{"issue":"9","key":"3405_CR25","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/j.1526-4637.2011.01205.x","volume":"12","author":"M Safavi","year":"2011","unstructured":"Safavi M, Honarmand A, Nematollahy Z. Pre-incisional analgesia with intravenous or subcutaneous infiltration of ketamine reduces postoperative pain in patients after open cholecystectomy: a randomized, double-blind, placebo-controlled study. Pain Med. 2011;12(9):1418\u201326.","journal-title":"Pain Med"},{"issue":"1","key":"3405_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","volume":"129","author":"V Orhurhu","year":"2019","unstructured":"Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2019;129(1):241\u201354. https:\/\/doi.org\/10.1213\/ANE.0000000000004185.","journal-title":"Anesth Analg"},{"issue":"10","key":"3405_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s12630-011-9560-0","volume":"58","author":"K Laskowski","year":"2011","unstructured":"Laskowski K, Stirling A, McKay WP, Lim HJ. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011;58(10):911\u201323.","journal-title":"Can J Anaesth"},{"issue":"6","key":"3405_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.accpm.2018.09.006","volume":"37","author":"S Perbet","year":"2018","unstructured":"Perbet S, Verdonk F, Godet T, Jabaudon M, Chartier C, Cayot S, Guerin R, Morand D, Bazin JE, Futier E, Pereira B, Constantin JM. Low doses of ketamine reduce delirium but not opiate consumption in mechanically ventilated and sedated ICU patients: a randomised double-blind control trial. Anaesth Crit Care Pain Med. 2018;37(6):589\u201395. https:\/\/doi.org\/10.1016\/j.accpm.2018.09.006.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"10091","key":"3405_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0140-6736(17)31467-8","volume":"390","author":"MS Avidan","year":"2017","unstructured":"Avidan MS, Maybrier HR, Abdallah AB, Jacobsohn E, et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet. 2017;390(10091):267\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(17)31467-8.","journal-title":"Lancet"},{"issue":"3","key":"3405_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5055\/jom.2008.0023","volume":"4","author":"S Chazan","year":"2008","unstructured":"Chazan S, Ekstein MP, Marouani N, Weinbroum AA. Ketamine for acute and subacute pain in opioid-tolerant patients. J Opioid Manag. 2008;4(3):173\u201380.","journal-title":"J Opioid Manag"},{"issue":"2","key":"3405_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/08971900221134551","volume":"37","author":"CM Bell","year":"2024","unstructured":"Bell CM, Rech MA, Akuamoah-Boateng KA, et al. Ketamine in critically ill patients: use, perceptions, and potential barriers. J Pharm Pract. 2024;37(2):351\u201363.","journal-title":"J Pharm Pract"},{"issue":"5","key":"3405_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/AAP.0000000000000806","volume":"43","author":"ES Schwenk","year":"2018","unstructured":"Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, Bhatia A, Davis FN, Hooten WM, Cohen SP. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456\u201366. https:\/\/doi.org\/10.1097\/AAP.0000000000000806.","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"3405_CR33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.jvca.2019.11.020","volume":"34","author":"B Maranhao","year":"2019","unstructured":"Maranhao B, et al. What Is the role of ketamine in postoperative pain management? J of Cardiothorac Vasc Anesth. 2019;34(3):592\u20133.","journal-title":"J of Cardiothorac Vasc Anesth"},{"key":"3405_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.xjon.2021.03.022","volume":"7","author":"MC Grant","year":"2021","unstructured":"Grant MC, et al. Is it time to eliminate the use of opioids in cardiac surgery? JTCVS Open. 2021;7:247\u201352.","journal-title":"JTCVS Open"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03405-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:11:37Z","timestamp":1743739897000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03405-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3405"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03405-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5434679\/v1","asserted-by":"object"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was reviewed and approved by the institutional review board of New York University, reference number i24-00258. The board determined that this study, as a retrospective observational study without identifying protected health information, qualified for a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and approval and consent to participate"}},{"value":"There is no individual or identifying data in the study that would necessitate consent for publishing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}